U.S., March 5 -- An application to own the trademark for 'CANTEX' has been filed on Jun. 14, 2023.
Owner(s):
Cantex Pharmaceuticals, Inc.; 1792 Bell Tower Lane, , Florida
Goods and/or Services:
For: Pharmaceuticals, namely, Receptor for Advanced Glycation End products (RAGE) inhibitors for the treatment of cancer and other serious illnesses; Pharmaceutical preparations for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases; Pharmaceutical preparations for inhibiting Receptor for Advanced Glycation End products (RAGE) interactions, for the treatment of cancer and other serious illnesses, namely, infectious diseases, viral diseases, and autoimmune diseases; Pharmaceuti...